Whitehawk Therapeutics, Inc. (WHWK) Misses Q2 EPS by 101c
Get Alerts WHWK Hot Sheet
Join SI Premium – FREE
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q2 EPS of ($0.76), $1.01 worse than the analyst estimate of $0.25.
For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- Lodestar Metals signs $75,000 investor relations deal with NIA
- ReconAfrica launches C$15M bought-deal offering for drilling program
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share